Product Images Nifedipine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Nifedipine NDC 0904-7081 by Major Pharmaceuticals, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

0b564dde 2149 4f5c 900b 301a95138a61 00

0b564dde 2149 4f5c 900b 301a95138a61 00

This is a product label for Nifedipine extended-release tablets, a prescription medication used to treat hypertension and angina. The label includes the drug's National Drug Code (NDC) number, dosage, and quantity. The remaining text is not clear and appears to be gibberish.*

0b564dde 2149 4f5c 900b 301a95138a61 01

0b564dde 2149 4f5c 900b 301a95138a61 01

NIFEdipine Extended-Release tablets are sold in bottles of 100 units. Each tablet is extended-release and contains 80mg of NIFEdipine. This medication requires a prescription to be filled and should be kept out of reach of children. The manufacturer is Major Pharmaceuticals. The listed NDC number is 0904-7081-61.*

0b564dde 2149 4f5c 900b 301a95138a61 02

0b564dde 2149 4f5c 900b 301a95138a61 02

This is a description of two different drugs for hypertension. The first drug has a National Drug Code (NDC) of 0904-7080-61 and contains 100 unit dose tablets. The drug is Nifedipine, an extended-release medication in tablet form. The second drug has an NDC of 0904-7080-81 and contains 30mg of Nifedipine. The instructions state to swallow the extended-release tablets whole and not divided. The location and manufacturer information is unclear.*

01 - image 01

01 - image 01

02 - image 02

02 - image 02

This is a table showing the adverse effects of Nifedipine extended-release tablets versus a placebo, based on a sample size of 707 and 266 respectively. Adverse effects include headache, fatigue, dizziness, constipation, and nausea. Percentages of occurrence are provided for each adverse effect.*

03 - image 03

03 - image 03

This is a table that shows the percentage of adverse effects reported during a clinical trial comparing the use of Nifedipine capsules to a placebo. The trial had 226 participants using the capsules and 235 using the placebo. The adverse effects reported are dizziness, lightheadedness, giddiness, flushing, heat sensation, headache, weakness, nausea, heartburn, muscle cramps, tremor, peripheral edema, nervousness, mood changes, palpitations, dyspnea, cough, wheezing, nasal congestion, and sore throat.*

04 - image 04

04 - image 04

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.